CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REVCATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪1.62 B‬TWD
Fund flows (1Y)
‪−594.04 M‬TWD
Dividend yield (indicated)
Discount/Premium to NAV
−0.6%

About CATHAY SECURITIES CORPORATION GLOBAL GENOMICS IMMUNOLOGY & MEDICAL REV


Issuer
Cathay Financial Holdings Co., Ltd.
Brand
Cathay
Expense ratio
1.05%
Inception date
Nov 22, 2021
Index tracked
Solactive Global Genomics Immunology and Medical Revolution Index - Benchmark TR Net
Management style
Passive
ISIN
TW0000089804
1 90%() 2 1 () 100%

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of January 8, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.56%
Health Technology97.84%
Health Services1.73%
Bonds, Cash & Other0.44%
Cash0.44%
Stock breakdown by region
77%15%6%
North America77.74%
Europe15.64%
Asia6.62%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows